2019년 5월 14일 08:50

TRIGR Therapeutics Announces Formation of Global Clinical & Scientific Advisory Board

TRIGR Therapeutics, Inc. (“TRIGR”), a clinical stage biotechnology company focused on the development of multi-targeted and immunomodulatory bispecific antibodies, announced today the formation of its global Clinical and Scientific Advisory Board ...